Skip Navigation LinksGenitourinary

​​​​​​​​​​​​Genitourinary Trials

Cancer Control/Prevention 

​Bladder and Urothelial

S1605:  Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Renal Cell, Adjuvant & High Risk

Renal Cell, Locally Advanced or Metastatic


Prostate, Adjuvant & Early Stage

​​R0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

GU002: Phase II-III Trial Of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or without Adjuvant Docetaxel​


Prostate, Advanced & Metastatic

​S1216 (CIRB): A Phase III Randomization Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer

ONC-MA-1004 (TRUMPET): A Prospective Observational Cohort STudy of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States